Last reviewed · How we verify
Cortrosyn
At a glance
| Generic name | Cortrosyn |
|---|---|
| Also known as | ACTH, Cosyntropin |
| Sponsor | University of Virginia |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Updated Diagnostic Cortisol Values for Adrenal Insufficiency (NA)
- Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4) (EARLY_PHASE1)
- Stress and the Nervous System (NA)
- Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women (EARLY_PHASE1)
- Hormonal Mechanisms of Sleep Restriction - Axis Study (PHASE1)
- Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE) (PHASE2)
- Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease (EARLY_PHASE1)
- Defining the Mechanisms Underlying Adrenal Insufficiency in Cirrhosis
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |